We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
These documents explain how OHID is approaching reduction and food and drink reformulation as part of the government’s obesity strategy.
Description of scarlet fever, potential complications of the disease and advice on who's most at risk and how to prevent the spread.
This document sets out the government's vision for putting prevention at the heart of the nation's health.
Find out about the long-term effects some people can have after having COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (30 January 2024) approved the medicine momelotinib (Omjjara) to treat the symptoms experienced by adult myelofibrosis patients who have moderate or severe anaemia (a low number of red blood cells...
Public health principles to support planning for events and mass gatherings during the current mpox outbreak.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Actions that trial sponsors should consider to build resilience into clinical trial design
Explore the impact of parental conflict on children and young people.
How to use A/B testing to evaluate your digital health product.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.